Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02676427
Other study ID # 530/15 S-IV
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 2015
Est. completion date June 2021

Study information

Verified date August 2019
Source Charles University, Czech Republic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aims at clarification of venous collapsibility measures with real venous flow measurements during dynamic maneuver testing fluid responsiveness in septic shock patients.


Description:

Sedated and mechanically ventilated patients in septic shock will be enrolled in the study. A fine catheter with ultrasound doppler probe will be introduced into the central venous catheter already in place in superior vena cava. Doppler signal will be evaluated by console prototype (NILUS Medical) and continuous analysis of blood flow velocity respiratory variation will be performed. These values will be compared to standard hemodynamic monitoring parameters (central venous and arterial pressures) and to parameters acquired by transoesophageal (TOE) and transthoracic echocardiography.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 2021
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients in severe sepsis or septic shock

- intubation and mechanical ventilation

- sedated patient without spontaneous respiratory efforts

- central venous catheter in place inserted via right internal jugular vein

- signed informed consent by family members

Exclusion Criteria:

- superior vena cava vascular anomaly

- irradiation of neck or mediastinum in medical history

- thrombosis of superior vena cava in medical history

- atrial fibrillation or other irregular rhythm

- permanent or external pacemaker

- aggressive mechanical ventilation (PEEP above 10 cm H2O, Pmax above 30 cm H2O)

- TOE contraindication (oesophageal varices, stricture, tumour, upper gastrointestinal bleeding)

- Pericardial effusion, constrictive pericarditis

- Moderate or severe valvular lesion

- Severe systolic dysfunction of the left (EF less than 30%) or right ventricle (FAC less than 25%)

- Intraabdominal pressure above 20 mmHg

- Open chest

- Obvious severe hypovolemia ( LVEDA<5.5cm2/m2BSA)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
passive leg raising
passive leg raising under echocardiographic monitoring with intravascular doppler in place

Locations

Country Name City State
Czechia Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University Prague 2

Sponsors (1)

Lead Sponsor Collaborator
Charles University, Czech Republic

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fluid responsiveness Evaluation of fluid responsiveness, defined as 15% increase of cardiac output after reversible fluid challenge (using PLR - passive leg raise maneuver), by ultrasound doppler evaluation of superior vena caval blood flow respiratory variation. through the study, data collection during 1 year
Secondary Change of flow Evaluation of fluid responsiveness by measuring a change of blood flow velocity after PLR maneuver. through the study, data collection during 1 year
Secondary Respiratory variation of flow velocity Evaluation of fluid responsiveness by measuring respiratory variation of blood flow velocity in left ventricular outflow tract after PLR maneuver through the study, data collection during 1 year
Secondary Respiratory collapsibility Evaluation of fluid responsiveness by measuring respiratory collapsibility of inferior vena cava after PLR maneuver. through the study, data collection during 1 year
Secondary Respiratory collapsibility Evaluation of fluid responsiveness by measuring respiratory collapsibility of superior vena cava after PLR maneuver through the study, data collection during 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT03649633 - Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock Phase 1/Phase 2
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Completed NCT05629780 - Temporal Changes of Lactate in CLASSIC Patients N/A
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT05066256 - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02580240 - Administration of Hydrocortisone for the Treatment of Septic Shock N/A
Completed NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock Phase 3
Not yet recruiting NCT02547467 - TOADS Study: TO Assess Death From Septic Shock. N/A
Terminated NCT02335723 - ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber N/A
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4
Completed NCT02204852 - Co-administration of Iloprost and Eptifibatide in Septic Shock Patients Phase 2
Completed NCT02306928 - PK Analysis of Piperacillin in Septic Shock Patients N/A